S. Gil-Vernet

Face transplant: long-term follow-up and results of a prospective open study

F. Bellivier, J. Lefaucheur, P. Wolkenstein, 2016, The Lancet.

Population Pharmacokinetics of Ganciclovir after Intravenous Ganciclovir and Oral Valganciclovir Administration in Solid Organ Transplant Patients Infected with Cytomegalovirus

H. Colom, N. Lloberas, J. Grinyó, 2009, Antimicrobial Agents and Chemotherapy.

Cyclosporine-drug interactions.

J. Griño, S. Gil-Vernet, I. Sabaté, 1988, Transplantation proceedings.

Value of monitoring circulating donor‐reactive memory B cells to characterize antibody‐mediated rejection after kidney transplantation

J. Grinyó, D. Bernal-Casas, A. Loupy, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.

F. Moreso, D. Serón, J. Cruzado, 2005, Transplantation proceedings.

Baseline Immunosuppression is Associated with Histological Findings in Early Protocol Biopsies

F. Moreso, D. Serón, J. Cruzado, 2004, Transplantation.

Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics

H. Colom, J. Torras, J. Grinyó, 2009, Transplant infectious disease : an official journal of the Transplantation Society.

Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression.

M. J. Castiñeiras, A. Martínez‐Castelao, D. Serón, 2002, Transplantation proceedings.

Renal Transplantation (RT) in Diabetic Nephropathy (DN) in the 80’s Decade

D. Serón, S. Gil-Vernet, J. Bover, 1991 .